Condition Overview

Alzheimer’s & Dementia Support

For families asking what is known, and what is not, about regenerative research in dementia.

Cellular artwork for Alzheimer’s & Dementia Support Personalized review, grounded in your health history.

Understanding Alzheimer's and dementia

Alzheimer’s disease is the most common form of dementia. It gradually affects memory, thinking, reasoning, and the ability to manage everyday activities. Other conditions can also cause dementia symptoms, so a careful diagnosis and ongoing care from a neurologist, geriatrician, or memory clinic are essential.

Cellular and regenerative approaches are being studied, but they are not established care for Alzheimer’s disease or other dementias. No exosome product or stem cell product is FDA approved for these conditions. A consultation here does not replace diagnostic testing, medication management, safety planning, or caregiver support.

Most people who contact us about dementia are not the patient. If you are arranging this for a parent or a partner, you can make the enquiry, take part in the consultation, and ask the questions you have been carrying. What we offer is a licensed-provider review of the person’s history, current treatment, goals, and questions. Where cognitive impairment affects the ability to consent, the provider will explain what is required, which may include a healthcare proxy or power of attorney, and you will be told before anything is scheduled. The provider explains what current research does and does not show and may determine that no further assessment is appropriate.

We will not tell you that memory loss can be reversed. There is no approved cell therapy for Alzheimer’s disease or any other dementia, and families in this position are a specific target for unsupported claims. If a clinic tells you otherwise, ask them for the clinical trial registration and the name of the reviewing body.

A sudden change in alertness, confusion that develops over hours or days, or new agitation alongside fever or pain is not typical progression and needs urgent medical assessment. Contact the treating clinician the same day, or call 911 if the person is acutely unwell.

Potential Benefits

A memory-care consultation may help you or the person you care for:

  • A structured review of the diagnosis, the current treatment, and what the family needs to understand
  • A clear account of what cell-based research has and has not established in dementia
  • Screening for factors that may affect eligibility, including capacity to consent
  • Questions to discuss with your neurologist or memory-care team
  • A realistic next step, which is often a question for the memory clinic rather than anything we offer

Who May Benefit

A memory-care assessment may make sense for families including:

  • People with a confirmed diagnosis who remain under a neurologist's or memory clinic's care
  • Families seeking a clear explanation of current regenerative research and its limits
  • Caregivers preparing questions for the treating clinical team
  • People who prefer an initial assessment without traveling to another clinic
  • Individuals willing to coordinate any discussion with their existing physicians

Therapies a Provider May Consider

Every option is reviewed individually after your history, current care, and goals are understood.

What the Research Looks At

Research involving cells, signaling particles, and neurodegenerative disease remains experimental and has not established an approved treatment for Alzheimer's disease or dementia. The references below distinguish established condition guidance from early research and include the FDA's consumer warning.

  1. What Is Alzheimer's Disease? National Institute on Aging, NIH
  2. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes U.S. Food and Drug Administration
  3. Registered clinical trials related to Alzheimer's Disease ClinicalTrials.gov, U.S. National Library of Medicine

Start With an Assessment

Every visit begins with a consultation and a medical screening. A licensed provider decides what, if anything, is appropriate for you.

Terms you may hear when discussing dementia care

Families arranging care for a parent or partner meet a lot of new terms quickly. These are the ones that shape what a consultation here can and cannot involve.

  • Mild cognitive impairment. Changes in memory or thinking that are greater than expected for age but do not yet interfere enough with daily life to meet the criteria for dementia. Some people with it progress to dementia and some do not, which is why follow-up with a memory clinic matters.
  • Cognitive assessment. Structured tests such as the MoCA or MMSE that a clinician uses to measure memory, attention, language and other functions and to track change over time. They are part of diagnosis, not a substitute for it.
  • Healthcare proxy and power of attorney. Legal arrangements that allow a named person to make healthcare decisions when someone can no longer consent for themselves. If cognitive impairment affects consent, the provider will explain which is required before anything is scheduled.
  • Care partner. The family member or friend who helps manage appointments, records and daily needs. Care partners are welcome in the consultation and are usually the people asking the questions.

A licensed provider reviews the person’s history, current treatment, goals and questions with the family before deciding whether any supportive assessment is appropriate, and may determine that none is. Nothing offered is a treatment for Alzheimer’s disease or any other dementia.

Related conditions in this care area: Parkinson’s Disease, Peripheral Neuropathy and Post-Stroke and Cognitive Decline. Back to Neurological Support.

Alzheimer’s & Dementia Support

Frequently Asked Questions

No. Nothing offered here is a cure or an approved treatment for Alzheimer's disease or another dementia. The purpose of the consultation is to review your history, explain the limits of current research, and decide whether any supportive assessment is appropriate.
No. Diagnosis, medication management, safety planning, and caregiver support stay with the neurologist, geriatrician, or memory clinic. This consultation sits alongside that care and does not replace it.
Intake information is shared and a medical screening is completed, and a family member or legally authorized representative may do this on the person's behalf. A licensed provider then reviews the diagnosis, the current treatment, and the family's questions, and explains what is required on consent and capacity. Only after that review can the provider decide whether any next step is appropriate.
A licensed provider makes that decision after reviewing your history and screening information. Not everyone is eligible, and being told that no further step is appropriate is a normal outcome of an honest assessment.
Hitech Regen serves Southern California. Availability and suitability are discussed during the consultation before any visit is scheduled.
Cost is discussed after a licensed provider determines whether anything is appropriate to consider. We do not quote a condition-specific plan before the assessment.
Yes, and often that is the sensible thing to do. Bring whoever manages appointments and records. The consultation involves reviewing history, current care and goals, and that is easier with the person who holds the paperwork in the room.
We make no claim of that kind. Nothing offered here is a cure and no product we work with is FDA approved for Alzheimer's disease or any other dementia.
Consent is part of the consultation and a licensed provider handles it. If someone holds power of attorney or is the named health proxy, say so at intake so it is clear from the start.
No. We do not manage dementia. Anything discussed here sits alongside that care, and we would expect you to tell the treating team about it.
Book a Consultation